The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Probiotics in Medicine: A Long Debate
Open accessAbstract
During the last years probiotics gained the attention of clinicians for their use in the prevention and treatment of multiple diseases. Probiotics main mechanisms of action include enhanced mucosal barrier function, direct antagonism with pathogens, inhibition of bacterial adherence and invasion capacity in the intestinal epithelium, boosting of the immune system and regulation of the central nervous system. It is accepted that there is a mutual communication between the gut microbiota and the liver, the so-called "microbiota-gut-liver axis" as well as a reciprocal communication between the intestinal microbiota and the central nervous system through the "microbiota-gut-brain axis." Moreover, recently the "gut-lung axis" in bacterial and viral infections is considerably discussed for bacterial and viral infections, as the intestinal microbiota amplifies the alveolar macrophage activity having a protective role in the host defense against pneumonia. The importance of the normal human intestinal microbiota is recognized in the preservation of health. Disease states such as, infections, autoimmune conditions, allergy and other may occur when the intestinal balance is disturbed. Probiotics seem to be a promising approach to prevent and even reduce the symptoms of such clinical states as an adjuvant therapy by preserving the balance of the normal intestinal microbiota and improving the immune system. The present review states globally all different disorders in which probiotics can be given. To date, Stronger data in favor of their clinical use are provided in the prevention of gastrointestinal disorders, antibiotic-associated diarrhea, allergy and respiratory infections. We hereby discuss the role of probiotics in the reduction of the respiratory infection symptoms and we focus on the possibility to use them as an adjuvant to the therapeutic approach of the pandemic COVID-19. Nevertheless, it is accepted by the scientific community that more clinical studies should be undertaken in large samples of diseased populations so that the assessment of their therapeutic potential provide us with strong evidence for their efficacy and safety in clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Dinleyici, E. Ç., Kara, A., Dalgıç, N., Kurugöl, Z., Arıca, V., Akcan, Ö. M., Temur, E., Türel, Ö., Güven, Ş., Yasa, O., et al. (2015) · Beneficial Microbes · doi:10.3920/bm2014.0086 · Cited by 47
Yao, P., Tan, F., Gao, H., Wang, L., Yang, T., & Cheng, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6226 · Cited by 46
Effects of the Probiotic Formulation VSL#3 on Colitis in Weanling Rats
Fitzpatrick, L. R., Hertzog, K. L., Quatse, A. L., Koltun, W. A., Small, J. S., & Vrana, K. E. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31803bda51 · Cited by 45
Rosenstein, I. J. M., Fontaine, E. A., Morgan, D. J., Sheehan, M., Lamont, R., & TAYLOR‐ROBINSON, D. (1997) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01708235 · Cited by 45
Effects of synbiotic fermentation products on primary chemoprevention in human colon cells
Stein, K., Borowicki, A., Scharlau, D., Schettler, A., Scheu, K., Obst, U., & Glei, M. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.03.022 · Cited by 38
The CF gastrointestinal microbiome: Structure and clinical impact
Rogers, G. B., Narkewicz, M. R., & Hoffman, L. R. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23544 · Cited by 37
Use of Probiotic Bacteria for Prevention and Therapy of Allergic Diseases
Felice, G. D., Barletta, B., Butteroni, C., Corinti, S., Tinghino, R., Colombo, P., & Boirivant, M. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318169c463 · Cited by 32
Targeting Food Allergy with Probiotics
Paparo, L., Nocerino, R., Scala, C. D., Gatta, G. D., Costanzo, M. D., Buono, A., Bruno, C., & Canani, R. B. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_316 · Cited by 32
Das, R. R., Naik, S. S., & Singh, M. (2013) · BioMed Research International · doi:10.1155/2013/231979 · Cited by 31
Pharmacokinetics of Probiotics and Biotherapeutic Agents in Humans
Marteau, P. R., & Vesa, T. H. (1998) · Bioscience and Microflora · doi:10.12938/bifidus1996.17.1 · Cited by 27
Magklis, E., Howe, L. D., & Johnson, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-51534-w · Cited by 27
Human microbiota in aging and infection: A review
Stavropoulou, E., & Bezirtzoglou, E. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1379469 · Cited by 26
Self-citationOcaña, V. S., & Nader-Macías, M. E. (2004) · Humana Press eBooks · doi:10.1385/1-59259-766-1:347 · Cited by 25
Autism spectrum disorder, functional MRI and MR spectroscopy: possibilities and challenges
Hugdahl, K., Beyer, M. K., Brix, M. K., & Ersland, L. (2012) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v23i0.18960 · Cited by 23
Sullivan, Å., Bennet, R., Viitanen, M. H., Palmgren, A., & Nord, C. E. (2002) · Microbial Ecology in Health and Disease · doi:10.1080/089106002760003305 · Cited by 22
Rittiphairoj, T., Pongpirul, K., Mueller, N. T., & Li, T. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1145-y · Cited by 19
[Cholesterol-lowering effects of probiotics--a review].
Guo, C., & Zhang, L. (2010) · PubMed · Cited by 15
Use of probiotic bacteria as an adjuvant for an influenza vaccine.
French, P. W., & Penny, R. (2009) · International Journal of Probiotics and Prebiotics · Cited by 14
Probiotics as a promising treatment for inflammatory bowel disease
Mikov, M., Stojančević, M., & Bojić, G. (2014) · Hospital Pharmacology - International Multidisciplinary Journal · doi:10.5937/hpimj1401052m · Cited by 13
Viral recognition by the innate immune system: the role of pattern recognition receptors
Pedraza, S. T., Betancur, J. G., & Inchima, S. U. (2011) · Colombia medica · Cited by 12
Stress-Induced Alterations in Intestinal Microflora
Tsiotsias, A., Voidarou, C. C., Skoufos, J., Simopoulos, C. E., Konstandi, M., Kostakis, D., & Bezirtzoglou, E. (2004) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v16i1.7953 · Cited by 11
Self-citationVassos, D., Bezirtzoglou, E., Voidarou, C. C., Alexopoulos, A., & Maipa, V. (2009) · Microbial Ecology in Health and Disease · doi:10.3109/08910600903495095 · Cited by 10
Self-citationKachrimanidou, M., Tsachouridou, Ο., Ziogas, I. A., Christaki, E., Protonotariou, E., Metallidis, S., Skoura, L., & Kuijper, E. J. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000623 · Cited by 10
Probiotics in allergy treatment: a literature review
Crovesy, L., Gongalves, D., & Trigo, E. L. (2017) · Revista Española de Nutrición Humana y Dietética · doi:10.14306/renhyd.21.3.361 · Cited by 10
Stress-induced alterations in intestinal microflora
Tsiotsias, A., Voidarou, C. C., Skoufos, J., Simopoulos, C. E., Konstandi, M., Kostakis, D., & Bezirtzoglou, E. (2004) · Microbial Ecology in Health and Disease · doi:10.1080/08910600410028632 · Cited by 10
Self-citation[Efficacy and safety of probiotics].
Graf, C., & Sarasin, F. (2007) · PubMed · Cited by 3
Cited by
Probiotics, prebiotics, and postbiotics in health and disease
Ji, J., Jin, W., Liu, S., Jiao, Z., & Li, X. (2023) · MedComm · doi:10.1002/mco2.420 · Cited by 384
Lamichhane, B., Mawad, A. M. M., Saleh, M., Kelley, W. G., Harrington, P. J., Lovestad, C. W., Amezcua, J., Sarhan, M. M., El Zowalaty, M. E., Ramadan, H., et al. (2024) · Antibiotics · doi:10.3390/antibiotics13010076 · Cited by 353
How do intestinal probiotics restore the intestinal barrier?
Gou, H.-Z., Zhang, Y.-L., Ren, L.-F., Li, Z.-J., & Zhang, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.929346 · Cited by 305
Alizadeh Behbahani, B., Jooyandeh, H., Taki, M., & Falah, F. (2024) · LWT · doi:10.1016/j.lwt.2024.116676 · Cited by 59
Tang, Q., Hao, Y., Wang, L., Lu, C., Li, M., Si, Z., Wu, X., & Lu, Z. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02253-8 · Cited by 20
Metadata
- Authors
- Stavropoulou, E., & Bezirtzoglou, E.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-09-25
- Volume
- 11
- Pages
- 2192-2192
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3088143070
- Cited by
- 282
- References
- 226
- FWCI
- 21.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.